Navigation Links
B. Riley Revises Timing of STAAR Surgical Presentation at Investor Conference
Date:5/21/2012

MONROVIA, Calif., May 21, 2012 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that its presentation time at the 13th Annual B. Riley & Co. Investor Conference has been revised and will be on Wednesday, May 23, 2012 now at 1:30 p.m. Pacific Time.Barry G. Caldwell, President and CEO, will review the company's recent financial results and current business developments. Deborah Andrews, CFO, will also be attending.  STAAR will offer a live video webcast of its presentation on the Company's website, www.staar.com, under Investor Information. An archived replay of the presentation will be available for 30 days, also at www.staar.com.

About STAAR SurgicalSTAAR, which has been dedicated solely to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye.  All of these lenses are foldable, which permits the surgeon to insert them through a small incision.  STAAR's lens used in refractive surgery as an alternative to LASIK is called an Implantable Collamer® Lens or "ICL."  A lens used to replace the natural lens after cataract surgery is called an intraocular lens or "IOL."  Over 300,000 Visian ICLs have been implanted to date; to learn more about the ICL go to: www.visianinfo.com.  STAAR has approximately 300 full time employees and markets lenses in over 60 countries.  Headquartered in Monrovia, CA, it manufactures in the following locations: Nidau, Switzerland; Ichikawa City, Japan; Aliso Viejo, CA; and Monrovia, CA.  For more information, please visit the Company's website at www.staar.com
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Tulsa Shock Guard Andrea Riley and NBA Legend Bob Lanier Join Vaccines for Teens Educational Campaign to Urge Local Teens to Take Their Best Shot at Health
2. Adeona Appoints Jeff Lucero Riley as Independent Chairman
3. Heska to Present at B. Riley Investor Conference
4. Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance
5. Sinovac Announces Preliminary Unaudited Third Quarter 2010 Sales Range and Revises Full Year 2010 Sales Expectations
6. PDL BioPharma Revises Second Quarter 2011 Revenue Guidance to $122 Million
7. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Fralex provides update on timing of interim analysis results
10. Takeda to Revise Timing of Alogliptin and Alogliptin/ACTOS MAA Filings in Europe
11. Anthera Announces Conference Call to Discuss Analytical Method and Timing of Upcoming VISTA-16 Biomarker Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , 30. September 2014 ... http://photos.prnewswire.com/prnh/20130430/LA01948LOGO Acutus ... ein minimal-invasives 3D-Herzkammer-Bildgebungs- und Dipoldichte-Mappingsystem in ... die zu komplexen Herzrhythmusstörungen einschließlich Vorhofflimmern ... Abschluss einer zusätzlichen Finanzierung über 26,2 ...
(Date:9/30/2014)... , Sept. 30, 2014   Acutus ... minimally invasive real-time 3D Cardiac Chamber Imaging and Dipole ... and / or sustain complex cardiac arrhythmias, including atrial ... to continue developing its imaging/mapping system as well as ... will allow Acutus Medical to complete work on the ...
(Date:9/30/2014)... 30, 2014 In 2011, approximately 5.1 million ... abused prescription pain relievers (e.g. opioids). 1 Clinical ... which entails the use of buprenorphine, buprenorphine/naloxone, naltrexone or ... important when developing and improving care management programs, according ... Prime Therapeutics LLC (Prime). ...
Breaking Medicine Technology:Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 2Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 3Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 2Studies show cost and use of opioid dependence treatment are increasing, spurring the need for care management programs 3
... , , NEWPORT BEACH, Calif., ... data from a clinical study showing patient-specific cancer vaccines derived ... tolerated and resulted in impressive long-term survival rates in patients ... therapies. , , The study ...
... TARZANA, Calif., July 28 Less than two weeks ... Providence Tarzana Medical Center has applied the body-cooling treatment in ... , , Therapeutic hypothermia treatment, where cardiac ... nationwide to help prevent brain damage caused by a loss ...
Cached Medicine Technology:Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy 2Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy 3Treatment Shows Excellent Results for Providence Tarzana Patients Following Cardiac Arrest 2
(Date:9/30/2014)... Next to lung cancer, breast cancer is the leading ... American Cancer Society. That,s why so many medical professionals ... are imperfect at best: only a minority of suspicious ... results in lots of needless worry for women and ... of additional tests, including ultrasounds and biopsies. , ...
(Date:9/30/2014)... 2014 A new study of ... the impact of stress on metabolism after eating a high-fat ... from a fast food restaurant, about 930 calories and 60 ... 20 minutes every hour for 7 hours, conducting the study ... who had experienced a stressful event in their lives during ...
(Date:9/30/2014)... 30, 2014 Research by UC Irvine immunologists reveals ... light on a vital process that determines how the ... online version of Nature Immunology , neurology professor ... Institute for Immunology colleagues describe a critical mechanism underlying ... the bloodstream. , A T cell is a type ...
(Date:9/30/2014)... EverStryke , the permanent match currently offered ... with a free book and class all about survival education ... an investigative review. , “Joe Marshall of SurvivalLife.com is ... preparation niche, and this product is an excellent way to ... products that Joe offers on his website to help people ...
(Date:9/30/2014)... September 30, 2014 VisitandCare.com ... Turkey has gone up more than 79 percent in ... tourism company also reported total revenue tripled for its ... The company’s professional strategy has allowed them to partner ... designed for patient comfort and privacy — with state-of-the-art ...
Breaking Medicine News(10 mins):Health News:'Virtual breast' could improve cancer detection 2Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 2Health News:NutriGold Urges Every Woman To Read a Recent Study About Diet and Stress 3Health News:UCI study uncovers important process for immune system development 2Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4
... Healthcare Management Systems, Inc. (R) (HMS) ... Act of 2009 (ARRA) as it unfolds, ... the HIMSS informational webinar yesterday on ARRA, even with ... to wait to implement electronic health record (EHR) technology ...
... $.08 Per Diluted ShareLARGO, Fla., Feb. 26 ... TSX Venture Exchange: UVI), which develops, licenses, ... reported its operating results for the second quarter ... income, increased 1.2% to $1,530,242 in FY2009 second ...
... announced the completion of a 100 subject study demonstrating ... sodium intake. The test, which can be used either ... testing at the physician,s office, is revolutionary in providing ... sodium intake. It involves dipstick testing, with results ...
... are our calling cards. They identify who we are, ... of the five senses that deliver outside information to ... in the mirror does not reflect your true identity?To ... If you have considered undergoing a facial plastic surgery ...
... BOSTON, Feb. 26 Solos Endoscopy, Inc. (Pink Sheets: ... received a significant purchase order for the MammoView(TM) line ... The Waterbury Hospital, the cornerstone of the Greater ... with health care services since 1983 and is accredited ...
... IDM Pharma, Inc.,(Nasdaq: IDMI ) today ... Disorders (NORD) and more than 100 patient organizations, caregivers,researchers ... Disease Day on February 28. The goal of ... challenges encountered by those affected and the importance,of research ...
Cached Medicine News:Health News:HMS Responds to American Recovery and Reinvestment Act of 2009 2Health News:Unilens Vision Reports Record Second Quarter Revenue, and Royalty Income 2Health News:Unilens Vision Reports Record Second Quarter Revenue, and Royalty Income 3Health News:Unilens Vision Reports Record Second Quarter Revenue, and Royalty Income 4Health News:Unilens Vision Reports Record Second Quarter Revenue, and Royalty Income 5Health News:SaltCheck Develops First Simplified Test for Monitoring Salt Intake in People With Hypertension 2Health News:SaltCheck Develops First Simplified Test for Monitoring Salt Intake in People With Hypertension 3Health News:Video: Facing the Facts - What You Need to Know About Facial Plastic Surgery 2Health News:Solos Endoscopy, Inc. Receives Purchase Order from Major Connecticut Hospital for the MammoView(TM) 2Health News:IDM Pharma Joins NORD to Raise Awareness of Rare Diseases 2Health News:IDM Pharma Joins NORD to Raise Awareness of Rare Diseases 3Health News:IDM Pharma Joins NORD to Raise Awareness of Rare Diseases 4
... elbow, wrist, and hand. Appliance holding patient's ... the opposite shoulder. Abduction can be set ... attaches to pillow wedge at 90 angle. ... along length of arm. Humerus and wrist ...
... Combining the therapeutic benefits of controlled compression ... swelling, and pain. The anatomically designed cuff ... Shoulder Cryo/Cuff can be ordered with an ... larger chest circumferences.,All Cryo/Cuffs can be ordered ...
... comfortable pre-fabricated orthosis is designed for ... third humeral diaphyseal fractures. The lightweight ... soft tissue compression for optimal control ... range-of-motion of both the shoulder and ...
... to treat or help prevent lower ... hip displasia, foot drop, contractures and pressure ... lining provides a comfortable wicking interface for ... easily rotated and locked into a vertical ...
Medicine Products: